NAVLE Multisystemic

Equine Hypertriglyceridemia Study Guide

📅 March 28, 2026 ⏱ 25 min read

Hypertriglyceridemia represents a spectrum of lipid metabolism disorders in equids characterized by elevated serum triglyceride concentrations.

Overview and Clinical Importance

Hypertriglyceridemia represents a spectrum of lipid metabolism disorders in equids characterized by elevated serum triglyceride concentrations. This condition ranges from subclinical hyperlipidemia to life-threatening hyperlipemia with hepatic lipidosis and multiorgan failure. Understanding this continuum is essential for NAVLE success, as questions frequently test breed predispositions, pathophysiology, diagnostic thresholds, and treatment protocols.

The condition represents one of the most important metabolic emergencies in ponies, miniature horses, and donkeys. Mortality rates can reach 70-80% in severe cases, making early recognition and aggressive intervention critical for patient survival.

Term	Triglyceride Level	Plasma Appearance	Clinical Significance
Hypertriglyceridemia	Greater than 100 mg/dL (1.1 mmol/L)	Clear to slightly turbid	Subclinical; no organ infiltration
Hyperlipidemia	100-500 mg/dL (1.1-5.6 mmol/L)	Turbid; no gross lipemia	Warrants monitoring; intervention may be needed
Hyperlipemia	Greater than 500 mg/dL (5.6 mmol/L)	Grossly lipemic (milky white/opalescent)	EMERGENCY; hepatic lipidosis; multiorgan failure risk

Terminology and Classification

The terminology surrounding equine lipid disorders can be confusing. Understanding the distinctions is critical for both clinical practice and NAVLE questions.

High-YieldFor NAVLE, remember the key threshold: triglycerides greater than 500 mg/dL (5.6 mmol/L) with grossly lipemic (milky white) plasma defines hyperlipemia. This distinguishes the potentially fatal disease state from subclinical elevations.

Risk Category	Breeds/Species	Physiological Basis
HIGHEST RISK	Donkeys, Miniature horses, Shetland ponies, Welsh ponies	Enhanced VLDL production; efficient fat mobilization; inherent insulin resistance; higher glucagon:insulin ratio (donkeys)
HIGH RISK	All pony breeds, Morgans, Arabians, Paso Finos	"Easy keeper" phenotype; predisposed to obesity and insulin dysregulation; enhanced catecholamine sensitivity
MODERATE RISK	Quarter Horses, Tennessee Walking Horses, standard-size horses with PPID/EMS	Risk increases with concurrent endocrine disease; obesity; systemic illness
LOWER RISK	Thoroughbreds, Standardbreds	Generally more insulin sensitive; athletic metabolism; still at risk if severely ill/anorexic

Pathophysiology

Understanding the pathophysiology is fundamental to recognizing risk factors, clinical signs, and treatment rationale. The condition develops through a cascade of metabolic events triggered by negative energy balance.

Normal Lipid Metabolism

In normal equine metabolism, dietary fatty acids are absorbed from the gastrointestinal tract and transported via chylomicrons through the lymphatic system. During periods of negative energy balance, hormone-sensitive lipase (HSL) in adipose tissue is activated, releasing free fatty acids (FFAs) and glycerol into circulation. The liver extracts these FFAs and either oxidizes them for energy, uses them for gluconeogenesis, or re-esterifies them into triglycerides packaged as very low-density lipoproteins (VLDL) for export to peripheral tissues.

Pathophysiological Cascade

Step 1: Negative Energy Balance Trigger

Any condition causing decreased energy intake or increased energy demand initiates the cascade. Common triggers include anorexia, systemic illness, pregnancy, lactation, transportation stress, or overly aggressive dietary restriction in obese animals.

Step 2: Lipolysis Activation

Decreased insulin and increased counter-regulatory hormones (catecholamines, glucocorticoids, ACTH, glucagon) activate hormone-sensitive lipase, mobilizing FFAs from adipose stores. Ponies and donkeys have enhanced sensitivity to these lipolytic signals.

Step 3: Hepatic Overwhelm

The liver's capacity to oxidize incoming FFAs becomes saturated. Unlike ruminants, equids have limited ability to produce ketone bodies. Instead, FFAs are re-esterified to triglycerides and packaged into VLDL. Ponies are particularly efficient at VLDL production.

Step 4: VLDL Accumulation

When hepatic VLDL production exceeds peripheral clearance capacity (mediated by lipoprotein lipase), circulating triglycerides accumulate, causing plasma lipemia.

Step 5: Organ Infiltration

Excess lipids deposit in the liver (hepatic lipidosis), kidneys, heart, and skeletal muscle, causing progressive organ dysfunction. The liver becomes pale, enlarged, and friable with potential for rupture and fatal hemorrhage.

NAVLE TipUnlike cattle (which develop ketosis) and cats (which develop hepatic lipidosis from different mechanisms), equids have LIMITED KETONE PRODUCTION. This is why hyperlipemia in ponies involves massive triglyceride/VLDL elevation rather than ketosis.

Role of Insulin

Insulin is the key anti-lipolytic hormone. It inhibits hormone-sensitive lipase, suppresses lipolysis, and stimulates lipoprotein lipase for peripheral triglyceride clearance. Insulin resistance, common in obese ponies and those with Equine Metabolic Syndrome (EMS) or Pituitary Pars Intermedia Dysfunction (PPID), removes this protective brake on lipolysis, predisposing to hyperlipemia.

Category	Examples
Gastrointestinal	Colic, colitis/diarrhea, esophageal choke, dental disease
Reproductive	Late pregnancy (28% increased energy needs), lactation (87% increased energy needs), metritis, dystocia
Inflammatory/Infectious	Pneumonia, sepsis, endotoxemia, SIRS, laminitis
Endocrine	PPID (Cushing's disease), EMS, diabetes mellitus (type 2)
Stress/Management	Transportation, hospitalization, social disruption (donkeys pine for companions), severe weather
Iatrogenic	Aggressive feed restriction for weight loss, prolonged NPO for colic treatment, SGLT2 inhibitor therapy, corticosteroid administration
Other	Heavy parasitism, azotemia/renal disease (decreases VLDL clearance), neoplasia

Breed and Species Predisposition

Certain breeds and species are at markedly increased risk for developing hyperlipemia. This is one of the most commonly tested aspects of this topic on NAVLE.

High-YieldHospital prevalence data shows hypertriglyceridemia occurs in only 0.5% of hospitalized horses but 11-18% of hospitalized ponies, miniature horses, and donkeys. This dramatic difference underscores the importance of monitoring triglycerides in susceptible breeds during any illness.

Memory Aid

"DONKEYS Die from Lipids" - Donkeys, Obese ponies, Negative energy balance, Key trigger is anorexia, EMS/PPID predisposed, Yellow milky plasma, Stress/systemic illness precipitates

Parameter	Expected Finding	Clinical Significance
Triglycerides	Greater than 500 mg/dL (5.6 mmol/L) = Hyperlipemia; Normal horses: less than 100 mg/dL; Ponies/donkeys: less than 290 mg/dL may be normal	DIAGNOSTIC; Greater than 1200 mg/dL = poor prognosis
Hepatic Enzymes	Increased GGT, SDH, AST, ALP	Indicates hepatic lipidosis; SDH most liver-specific
Bile Acids	Often normal or mildly elevated	May not reflect severity; marked elevation indicates significant hepatic dysfunction
Bilirubin	Increased (hyperbilirubinemia)	From hepatic dysfunction and anorexia (horses fast-induced increase)
Glucose	Variable: hypoglycemia common in ponies; hyperglycemia if insulin resistant	Hypoglycemia = poor prognosis; hyperglycemia may indicate concurrent PPID/EMS
BUN/Creatinine	Often elevated (azotemia)	Renal lipidosis; dehydration; NOTE: lipemia can falsely elevate creatinine
Electrolytes	Hypokalemia common	From anorexia; requires supplementation
PT/PTT	May be prolonged	Hepatic coagulopathy; contraindicates heparin therapy

Risk Factors and Precipitating Conditions

Primary Risk Factors

Breed predisposition: Donkeys, miniature horses, ponies
Obesity: BCS greater than 7/9; larger adipose stores = more FFAs released
Insulin resistance: EMS, PPID, or breed-associated
Female sex: Mares overrepresented due to pregnancy/lactation energy demands

Precipitating Conditions

NAVLE TipNEVER use corticosteroids in animals at risk for or with hyperlipemia! Glucocorticoids enhance lipolysis and worsen the condition. This is a common NAVLE trap question.

Treatment	Protocol	Rationale/Notes
Address Primary Disease	Treat underlying condition (colic, infection, etc.)	Essential; hyperlipemia won't resolve if trigger persists
IV Dextrose	5% dextrose at maintenance rates (50-60 mL/kg/day); or 5-10 kcal/kg/day	Provides calories; stimulates endogenous insulin; inhibits lipolysis; monitor for hyperglycemia in IR animals
Enteral Nutrition	Voluntary feeding preferred; nasogastric tube feeding with high-carbohydrate gruel if anorexic	Physiologically superior; frequent small meals; offer palatable feeds (molasses, good hay, cereals)
Partial Parenteral Nutrition	Dextrose-amino acid solutions via jugular catheter	For patients unable to tolerate enteral; use polyurethane catheter; monitor for thrombophlebitis
Insulin Therapy	Regular insulin: 0.1-0.4 IU/kg IV/IM; or protamine zinc insulin 0.1-0.3 IU/kg IM q12-24h	Inhibits HSL; stimulates LPL; decreases lipolysis; MUST provide concurrent glucose; monitor for hypoglycemia
Fluid Therapy	Balanced polyionic fluids with KCl supplementation (20-40 mEq/L; no more than 0.5 mEq/kg/hr)	Correct dehydration; address hypokalemia; support renal perfusion
Heparin (Controversial)	150 IU/kg IV/SQ loading, then 125 IU/kg q8-12h	Stimulates LPL; CONTRAINDICATED if coagulopathy present; monitor aPTT; questionable efficacy if VLDL production (not clearance) is problem

Clinical Signs

Clinical signs of hyperlipemia are often nonspecific and may be masked by or confused with the primary disease process. Early recognition requires a high index of suspicion in susceptible breeds.

Early Signs

Anorexia/Inappetence - Most consistent finding; may refuse even favorite treats
Depression/Lethargy - Dull, quiet demeanor
"Sham eating" - Appears to eat but not actually consuming food
Decreased water intake

Progressive Signs

Weakness and ataxia - Muscle dysfunction from lipid infiltration
Ventral edema - From hypoproteinemia secondary to hepatic dysfunction
Icterus (jaundice) - Yellow mucous membranes from hepatic lipidosis
Diarrhea - Gastrointestinal dysfunction
Colic signs - Abdominal discomfort

Late/Severe Signs

Recumbency - Unable to stand
Muscle tremors/fasciculations
Hepatoencephalopathy - Obtunded mentation, head pressing, circling
Dysphagia - Difficulty swallowing (neurological)]
Acute collapse/death - From hepatic rupture with hemorrhagic shock

High-YieldThe absence of clinical signs does NOT rule out hyperlipemia. Some horses with endocrine disorders (PPID, EMS) have been documented with triglycerides exceeding 3000 mg/dL (34 mmol/L) while appearing clinically normal. ALWAYS check triglycerides in at-risk breeds with ANY illness.

Poor Prognostic Indicators	Better Prognostic Indicators
Triglycerides greater than 1200 mg/dL Triglycerides greater than 2000 mg/dL = rarely survive Hypoglycemia Hepatoencephalopathy signs Prolonged PT/PTT Severe azotemia Persistent anorexia despite treatment Recumbency	Triglycerides less than 1200 mg/dL Early recognition and treatment Return of appetite Treatable underlying cause Response to treatment within 24-48h Miniature horses (better than ponies) Standard-size horses (best prognosis)

Diagnosis

Clinical Diagnosis

Diagnosis is often suspected based on signalment (pony, donkey, miniature horse), history (anorexia, recent stress, concurrent illness), and gross observation of milky white to yellow plasma. However, severe hypertriglyceridemia can occur without visible lipemia.

Laboratory Findings

Diagnostic Imaging

Hepatic Ultrasound: The liver appears enlarged with diffuse hyperechogenicity. Intrahepatic portal vessels become difficult to visualize due to increased parenchymal echogenicity. While suggestive, ultrasound cannot definitively diagnose hepatic lipidosis; liver biopsy is required for confirmation.

Postmortem Findings

Gross necropsy reveals lipemic serum and a pale, enlarged, yellow, friable liver with a greasy texture on cut surface. The liver may rupture spontaneously, causing acute death from hemorrhagic shock into the peritoneal cavity. Kidneys and other organs may also show fatty infiltration.

Treatment

Treatment must be prompt and aggressive. The goals are to: (1) correct the underlying cause, (2) reverse the negative energy balance, (3) decrease lipid mobilization, and (4) support organ function.

NAVLE TipWhen using insulin, ALWAYS provide concurrent glucose to prevent hypoglycemia. Insulin may be ineffective in insulin-resistant patients. Monitor blood glucose closely (q2-4h initially). Heparin is CONTRAINDICATED in patients with hepatic coagulopathy (prolonged PT/PTT).

Monitoring Parameters

Triglycerides: Every 12-24 hours until consistently declining
Blood glucose: Every 2-4 hours if receiving insulin/dextrose
Appetite and attitude: Improvement often coincides with decreasing triglycerides
Hepatic enzymes: Every 24-48 hours
Renal values: BUN, creatinine, urine output
aPTT: If using heparin

Prognosis

Prognosis depends on the severity of hypertriglyceridemia, underlying cause, breed, and promptness of treatment. Overall mortality rates range from 40-80% in clinical hyperlipemia.

High-YieldKey NAVLE prognostic threshold: Triglycerides greater than 1200 mg/dL (13.5 mmol/L) is associated with markedly increased mortality. All patients with peak triglycerides greater than 1200 mg/dL died in one study of miniature horses, while those with lower values had 61% survival.

Prevention

Identify at-risk patients: Obese ponies, donkeys, miniature horses; those with EMS/PPID
Avoid aggressive feed restriction: Weight loss should be gradual (no more than 1% body weight/week)
Monitor during illness/hospitalization: Check triglycerides in any ill pony/donkey
Maintain adequate forage: Never restrict below 1.5% body weight in hay (dry matter) even for weight loss
Manage concurrent endocrine disease: Treat PPID with pergolide; manage EMS with diet/exercise
Minimize stress: Especially in donkeys (social animals); avoid prolonged transportation
Avoid corticosteroids: In predisposed breeds unless absolutely necessary

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →